Portfolio growth Arsenal specializes in middle-market industrial growth and healthcare, with a track record of building strategically important companies and raising over $10 billion in funds. Potential sales angle: offer scalable technology, data analytics, and AI-enabled platforms to support portfolio companies as they scale.
Tech augmentation Recent hires emphasize technology focus, including an investment partner dedicated to industrial technology strategies and OpenAI tooling in their tech stack. Potential sales angle: propose AI, automation, and cloud modernization solutions tailored to industrial and healthcare portfolio companies.
Recent exits Arsenal has actively exited investments such as MaxHealth to Humana, signaling strong exit discipline and value realization. Potential sales angle: present solutions that accelerate due diligence, integration, and value capture for buyers or lenders in similar mid-market healthcare and senior-care segments.
Expansion signals Leadership moves in business development for industrial growth and notable recaps like EspriGas indicate ongoing portfolio expansion and growth financing. Potential sales angle: offer growth-stage services, strategic advisory, and capital-efficient technology deployments to support recapitalizations and new acquisitions.
Cross-sector reach Arsenal operates across industrial growth and healthcare, with familiarity across private equity-backed rollups and platform investments. Potential sales angle: deliver cross-domain solutions (ERP, AI-enabled analytics, cyber resilience, and M&A integration tools) that serve both sectors and accelerate cross-portfolio synergies.